85 related articles for article (PubMed ID: 22248700)
1. Chronic hepatitis C: treatments of the future.
Bourlière M; Khaloun A; Wartelle-Bladou C; Oules V; Portal I; Benali S; Adhoute X; Castellani P
Clin Res Hepatol Gastroenterol; 2011 Dec; 35 Suppl 2():S84-95. PubMed ID: 22248700
[TBL] [Abstract][Full Text] [Related]
2. An update on the treatment of genotype-1 chronic hepatitis C infection: lessons from recent clinical trials.
Wendt A; Bourlière M
Ther Adv Infect Dis; 2013 Dec; 1(6):191-208. PubMed ID: 25165553
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C therapy in non-genotype 1 patients: the near future.
Wartelle-Bladou C; Le Folgoc G; Bourlière M; Lecomte L
J Viral Hepat; 2012 Aug; 19(8):525-36. PubMed ID: 22762136
[TBL] [Abstract][Full Text] [Related]
4. Chronic hepatitis C: future treatment.
Wendt A; Adhoute X; Castellani P; Oules V; Ansaldi C; Benali S; Bourlière M
Clin Pharmacol; 2014; 6():1-17. PubMed ID: 24470777
[TBL] [Abstract][Full Text] [Related]
5. Rapid progression of antiviral treatments of chronic hepatitis C virus infection.
Pol S; Corouge M; Mallet V; Sogni P
Minerva Gastroenterol Dietol; 2013 Jun; 59(2):161-72. PubMed ID: 23831907
[TBL] [Abstract][Full Text] [Related]
6. Antiviral activity of the new DAAs for the treatment of hepatitis C virus infection: virology and resistance.
Chevaliez S
Clin Res Hepatol Gastroenterol; 2011 Dec; 35 Suppl 2():S46-51. PubMed ID: 22248694
[TBL] [Abstract][Full Text] [Related]
7. Treatment of hepatitis C: perspectives.
Pol S; Corouge M
Med Mal Infect; 2014 Oct; 44(10):449-54. PubMed ID: 25174659
[TBL] [Abstract][Full Text] [Related]
8. Future of hepatitis C therapy: development of direct-acting antivirals.
Dore GJ; Matthews GV; Rockstroh J
Curr Opin HIV AIDS; 2011 Nov; 6(6):508-13. PubMed ID: 21897228
[TBL] [Abstract][Full Text] [Related]
9. Review of direct-acting antiviral agents for the treatment of chronic hepatitis C.
Shah N; Pierce T; Kowdley KV
Expert Opin Investig Drugs; 2013 Sep; 22(9):1107-21. PubMed ID: 23735127
[TBL] [Abstract][Full Text] [Related]
10. Drugs in development for chronic hepatitis C: a promising future.
Pockros PJ
Expert Opin Biol Ther; 2011 Dec; 11(12):1611-22. PubMed ID: 21995412
[TBL] [Abstract][Full Text] [Related]
11. Future treatment of chronic hepatitis C with direct acting antivirals: is resistance important?
Halfon P; Sarrazin C
Liver Int; 2012 Feb; 32 Suppl 1():79-87. PubMed ID: 22212577
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus and lipids in the era of direct acting antivirals (DAAs).
Sheridan DA; Neely RD; Bassendine MF
Clin Res Hepatol Gastroenterol; 2013 Feb; 37(1):10-6. PubMed ID: 22959093
[TBL] [Abstract][Full Text] [Related]
13. The race for interferon-free HCV therapies: a snapshot by the spring of 2012.
De Clercq E
Rev Med Virol; 2012 Nov; 22(6):392-411. PubMed ID: 22936636
[TBL] [Abstract][Full Text] [Related]
14. Treatment with daily consensus interferon (CIFN) plus ribavirin in non-responder patients with chronic hepatitis C: a randomized open-label pilot study.
Cornberg M; Hadem J; Herrmann E; Schuppert F; Schmidt HH; Reiser M; Marschal O; Steffen M; Manns MP; Wedemeyer H
J Hepatol; 2006 Feb; 44(2):291-301. PubMed ID: 16360972
[TBL] [Abstract][Full Text] [Related]
15. All Oral Interferon-free Direct-acting Antivirals as Combination Therapies to Cure Hepatitis C.
Shahid I; Ibrahim MM
Curr Mol Med; 2018; 18(7):409-435. PubMed ID: 30608042
[TBL] [Abstract][Full Text] [Related]
16. [Antiviral treatment of chronic hepatitis C].
Berger A
Med Monatsschr Pharm; 2012 Feb; 35(2):55-60. PubMed ID: 22400430
[TBL] [Abstract][Full Text] [Related]
17. Antiviral therapy: chronic hepatitis C.
Heathcote EJ
J Viral Hepat; 2007 Nov; 14 Suppl 1():82-8. PubMed ID: 17958648
[TBL] [Abstract][Full Text] [Related]
18. Future hepatitis C virus treatment: interferon-sparing combinations.
Gane E
Liver Int; 2011 Jan; 31 Suppl 1():62-7. PubMed ID: 21205140
[TBL] [Abstract][Full Text] [Related]
19. Viral interaction and responses in chronic hepatitis C and B coinfected patients with interferon-alpha plus ribavirin combination therapy.
Chuang WL; Dai CY; Chang WY; Lee LP; Lin ZY; Chen SC; Hsieh MY; Wang LY; Yu ML
Antivir Ther; 2005; 10(1):125-33. PubMed ID: 15751770
[TBL] [Abstract][Full Text] [Related]
20. A potent antiviral effect on hepatitis C viral dynamics in serum and peripheral blood mononuclear cells during combination therapy with high-dose daily interferon alfa plus ribavirin and intravenous twice-daily treatment with interferon beta.
Asahina Y; Izumi N; Uchihara M; Noguchi O; Tsuchiya K; Hamano K; Kanazawa N; Itakura J; Miyake S; Sakai T
Hepatology; 2001 Aug; 34(2):377-84. PubMed ID: 11481623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
